Early results released from a federal study found patients who received remdesivir had a 31% faster recovery time than those who received a placebo.
The world needs a coronavirus vaccine ASAP. Despite drugmakers billion-dollar bets, one might not be available for years.
"The data indicate there may be some benefit in overall mortality, these are preliminary data, we need to wait for final data," he said. "We don’t have enough data to know if that’s a statistically significant difference yet or not," Mehta said. The Chinese study hoped to enroll 325 patients but because the outbreak was waning in Wuhan, researchers were only able to enroll 237, reducing its statistical power from 80% to 58%. They called for larger studies to be done.“We believe remdesivir is the first medication to show a positive effect on patients with COVID-19,” he said."We look forward to more data coming to confirm these preliminary data.
An important question to answer moving forward is whether outcomes differed depending on when sick patients received the antiviral drug.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Drug Study Halted Early for Certain Covid-19 Patients After No Benefit SeenRegeneron and Sanofi said they will shut down part of a study exploring whether their arthritis therapy could treat certain hospitalized Covid-19 patients because the drug looked unlikely to help them.
Read more »
Gut microbes could predict how seriously ill a COVID-19 patient might get, preliminary study suggestsScientists studied data on over 2,000 people to explore the potential link between gut microbes and the disease caused by the coronavirus.
Read more »
Children, Women Just As Likely To Contract COVID-19, But Men Exhibit Worse Symptoms, Study SuggestsMen were 2.5x more likely to show severe symptoms than women, researchers found
Read more »
Children, Women Just As Likely To Contract COVID-19, But Men Exhibit Worse Symptoms, Study SuggestsChildren and women are just as likely to contract COVID-19, but men exhibit worse symptoms, a study suggests
Read more »
Study Shows Shorter Course of Gilead Drug as Effective Against Covid-19Gilead Sciences said its phase 3 study for the antiviral remdesivir demonstrated that patients with severe Covid-19 taking the drug over a five-day treatment had similar improvement compared with those taking the 10-day course.
Read more »
Gilead Sciences says there are 'positive data' from a study on possible Covid-19 treatment remdesivirThere's 'positive data' emerging from a study on possible Covid-19 treatment remdesivir, the maker of the investigational drug says
Read more »